Show simple item record

dc.contributor.authorZeng, Wu
dc.contributor.authorLi, Guohong
dc.contributor.authorTurbat, Vincent
dc.contributor.authorHu, Guoqing
dc.contributor.authorAhn, Haksoon
dc.contributor.authorShen, Jie
dc.date.accessioned2020-12-10T14:42:08Z
dc.date.available2020-12-10T14:42:08Z
dc.date.issued2020-11-10
dc.identifier.urihttp://hdl.handle.net/10713/14230
dc.description.abstractThe pandemic of Coronavirus Disease 2019 (COVID-19) highlights the importance of early detection of disease outbreaks, taking swift and decisive public health actions, and strengthening public health systems. Preventive medicine, as a specialty of medicine, trains students on both clinical medicine and public health and is of a particular need in battling against this pandemic. In China, preventive medicine plays a unique role in the disease control system where preventive medicine graduates represent a large share of the workforce. However, there is a shortage of qualified staff in the Chinese disease control system. The reasons for such a shortage are multifaceted. From the human resource perspective, the undergraduate preventive medicine curricula and exclusive public health training for preventive medicine postgraduates limit their clinical capacities. A series of disease control and public health education reforms may further incapacitate preventive medicine graduates' clinical skills, unintentionally widening the gap between public health and clinical medicine and thus posing threats to effective disease detection and control. The authors call for reforming and optimizing preventive medicine to bridge the gap between clinical medicine and public health by strengthening curricula on clinical medicine, diversifying curricula on public health, enhancing preventive medicine residency programs, and rectifying regulations that restrict preventive medicine graduates from practicing curative medicine.en_US
dc.description.urihttps://doi.org/10.1016/j.ypmed.2020.106324en_US
dc.language.isoenen_US
dc.publisherElsevier Ltd.en_US
dc.relation.ispartofPreventive Medicine Reportsen_US
dc.rightsCopyright © 2020 Elsevier Inc. All rights reserved.en_US
dc.subjectDisease controlen_US
dc.subjectHuman resourcesen_US
dc.subjectPreventive medicineen_US
dc.subjectPublic healthen_US
dc.titleOptimizing preventive medicine to bridge the gap between clinical medicine and public health for disease control in China: A lesson from COVID-19.en_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.ypmed.2020.106324
dc.identifier.pmid33186625
dc.source.journaltitlePreventive medicine
dc.source.volume143
dc.source.beginpage106324
dc.source.endpage
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record